# Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

> **NCT00803543** · NA · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 103 (actual)

## Conditions studied

- HIV
- HIV Infections

## Interventions

- **DRUG:** Valacyclovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00803543
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2017-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00803543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00803543, "Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00803543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*